[100-Year Science] Protein developed by US bio-firm reverses 70-year-old skin to 30-year-old appearance
Translated from Korean, summarized and contextualized by DistantNews.
At a glance
- U.S. scientists have developed a protein capable of reversing skin aging, effectively turning 70-year-old skin into that of a 30-year-old.
- The protein works by removing advanced glycation end products (AGEs), which are linked to aging and inflammation.
- If proven effective in human trials, this breakthrough could not only rejuvenate skin but also treat diseases affecting the retina, kidneys, and heart.
A groundbreaking development in anti-aging research has emerged from the United States, where scientists have engineered a protein that can reverse skin aging. This innovative protein has demonstrated the remarkable ability to transform skin from a 70-year-old appearance to that of a 30-year-old in laboratory cell experiments. The mechanism behind this rejuvenation involves the removal of advanced glycation end products (AGEs), compounds known to contribute to aging and inflammation within the body.
The U.S. bio-company Revel Pharmaceuticals is behind this significant advancement. While the initial results have been confirmed in cell cultures, the company and researchers are optimistic about its potential. If the efficacy of this protein is successfully validated in human clinical trials, the implications extend far beyond cosmetic improvements. The potential therapeutic applications could include treating age-related conditions and diseases affecting vital organs.
Beyond skin rejuvenation, the protein's ability to combat AGEs holds promise for treating a range of serious health issues. Conditions affecting the retina, kidneys, and heart, which are often exacerbated by the accumulation of AGEs, could potentially be treated or even prevented. This discovery marks a significant step forward in regenerative medicine, offering hope for more effective anti-aging therapies and treatments for chronic diseases associated with aging.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.